Resource Center: assessment, assessment

From Treatment Improvement Protocol (TIP) Series from SAMHSA, published in 2012. Title implies this is related to chronic opioid therapy for patients in recovery from substance use disorders, which it is, but it also is relevant to use of chronic opioid therapy for all patients and preventing substance use disorders.

Questionnaire for patients with chronic pain to determine level of functioning.

Practice Guidelines for Chronic Pain Management: An Updated Report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine. Evidence based guidelines for use of the different treatment modalities for chronic pain.

The 10-question Alcohol Use Disorders Identification Test (AUDIT) was developed by the World Health Organization (WHO) specifically for primary care settings as a screen for detecting at-risk or hazardous drinking. A shorter version of the AUDIT also is used in primary care and consists of the first 3 questions of the AUDIT.

Provides strategies to help reduce the prevalence of opioid abuse when prescribed: minimizing the risk, strategies to prevent misuse, and novel approaches to stopping misuse.

The Michigan Alcoholism Screening Test (MAST) is a 25-item questionnaire used to screen for alcohol abuse and dependence.

Bayesian analysis allows one to compare the likelihood of 2 outcomes based on recognized facts. This approach can be used to calculate a variety of probabilities important in medical genetics, including the likelihood of being a carrier following a negative carrier screen. To perform a Bayes analysis in this situation, one must first define the individual's initial carrier risk (prior probability) -- usually based on pedigree calculations or ethnicity data. That initial risk can then be modified based on the negative carrier screen result to determine a revised carrier risk (posterior probability). An example of a common calculation is shown below.

A list of clinical features and their frequency in both patients with pain and patients who are addicted to opioids.

The mood disorder questionnaire consists of five yes or no questions to be completed by the patient. The MDQ was developed by a team of psychiatrists, researchers and consumer advocates to address a critical need for timely and accurate diagnosis of bipolar disorder, which can be fatal if left untreated. The questionnaire takes about five minutes to complete, and can provide important insights into diagnosis and treatment.

A twenty-one question survey completed by a patient, with each answer scored on a scale of 0 to 3, designed to measure presence of depression.